Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.


TSXV:THRM - Post by User

Comment by hintonkidon Mar 02, 2022 12:52pm
113 Views
Post# 34475543

RE:Analyses

RE:AnalysesInvestors have been concerned over the delay in news confirming that THRM has delivered the data to the FDA for analysis and approval of the AcuiVid test.  If I recall from a previous news release, on this very subject, the company indicated that they were waiting on the lab that the PCR tests were submitted to to complete their work so that the THRM tests and the PCR test data could be submitted together to the FDA.  I have read that labs, in the US, that process PCR tests have been swamped, especially now that the government is providing free PCR tests that can be shipped to residents across the US and that people can take at home and then send to the labs.  It could simply be that with these labs being so busy it is just taking a bit longer to complete the PCR tests processing so that the data can be submitted with the THRM field test results.  I am sure that if the PCR tests were all submitted to a specify designated lab that if they are being processed as one lot investors should be hearing something from the company in the not too distant future.  We just need a little more patience.  I am sure that the reward will be well worth the wait.  Wishing everyone good fortune and good buys.
<< Previous
Bullboard Posts
Next >>